Health Care • Industrial Specialties
$232.14 ▲ +3.36
(+1.47%)
MKT CAP: $22.63B • VOL: 485.9K
52W L $195 52W H $269
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$195
MEDIAN
$260
MEAN
$265
HIGH
$316
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE STE TAPE
STE // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $280.89 | $266.96 | 2025-02-14 | $211.25 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $292.50 | $273.93 | 2025-02-06 | $218.21 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $264.64 | $255.35 | 2025-01-29 | $222.85 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $236.78 | — | 2025-01-17 | $227.50 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $204.28 | $220.53 | 2025-01-09 | $206.60 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $276.25 | $241.43 | 2024-12-18 | $201.96 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $225.18 | $234.46 | 2024-12-04 | $215.89 | -4.3% | 48% | C |